» Articles » PMID: 38438211

Hematological Malignancies: Prevalence and Hematological Characteristics in a Single Center in Southern Saudi Arabia

Overview
Journal Saudi Med J
Specialty General Medicine
Date 2024 Mar 4
PMID 38438211
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To determine the prevalence of leukemia in the Aseer region of Saudi Arabia and the importance of hematological, biochemical and coagulation profiles for leukemic patients in the context of disease management.

Methods: This retrospective study comprised 210 patients between 2012 and 2022 who had been diagnosed with leukemia at different ages. The multiple unpaired t-test was used to compare leukemic patients with control samples, which consisted of healthy individuals, and <0.05 was taken as significant. The data was compiled from Aseer Central Hospital in the Aseer region and collected through peripheral blood smear and bone marrow biopsy (2012-2017) or by flow cytometry (2018-2022), according to the hospital information system and registry data.

Results: Of the total 210 leukemic patients (61.4% males and 38.6% females), 104 cases (2012-2017) were diagnosed based on peripheral blood smear and bone marrow biopsy, and 106 cases (2018-2022) based on flow cytometry. Fifteen subtypes of leukemia were identified, with chronic myeloid leukemia being the most common (34.2%), followed by acute myeloid leukemia (17.6%), chronic lymphoblastic leukemia (11.9%), and B-cell acute lymphoid leukemia (9.5%). Other rare cases were also found.

Conclusion: Of the 210 leukemia cases diagnosed in the Aseer region between 2012-2022, the most common subtype was chronic myeloid leukemia, followed by acute myeloid leukemia. In all leukemia subtypes, distinctive significant changes were observed in hematological parameters, biochemical parameters, and coagulation profiles.

Citing Articles

STR profiling in a cohort of Saudi patients with acute leukemia.

Alhatim H, Abdullah M, Jamaludin S, Nurdin A, Amer S J Taibah Univ Med Sci. 2025; 20(1):62-72.

PMID: 40026413 PMC: 11869027. DOI: 10.1016/j.jtumed.2025.01.003.

References
1.
Dong Y, Shi O, Zeng Q, Lu X, Wang W, Li Y . Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol. 2020; 9:14. PMC: 7304189. DOI: 10.1186/s40164-020-00170-6. View

2.
Lad D, Jain A, Varma S . Complications and management of coagulation disorders in leukemia patients. Blood Lymphat Cancer. 2019; 7:61-72. PMC: 6467343. DOI: 10.2147/BLCTT.S125121. View

3.
Almetairi K, Alasmari S, Makkawi M, Shaikh A . Prevalence, hematological parameters, and coagulation profiles: Cardiovascular diseases statistics in the Asir region, Saudi Arabia. Saudi Med J. 2023; 44(4):385-393. PMC: 10153605. DOI: 10.15537/smj.2023.44.4.20220746. View

4.
Bawazir A, Al-Zamel N, Amen A, Akiel M, Alhawiti N, Alshehri A . The burden of leukemia in the Kingdom of Saudi Arabia: 15 years period (1999-2013). BMC Cancer. 2019; 19(1):703. PMC: 6637507. DOI: 10.1186/s12885-019-5897-5. View

5.
Shafique S, Tehsin S . Acute Lymphoblastic Leukemia Detection and Classification of Its Subtypes Using Pretrained Deep Convolutional Neural Networks. Technol Cancer Res Treat. 2018; 17:1533033818802789. PMC: 6161200. DOI: 10.1177/1533033818802789. View